These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16826854)

  • 1. 18F-fluorodeoxyglucose PET/CT in cancer imaging.
    Kayani I; Groves AM
    Clin Med (Lond); 2006; 6(3):240-4. PubMed ID: 16826854
    [No Abstract]   [Full Text] [Related]  

  • 2. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
    Hallett WA; Maguire RP; McCarthy TJ; Schmidt ME; Young H
    IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [18F-FDG-PET-CT in soft tissue sarcomas: when to image?].
    Rodríguez-Alfonso B; Mucientes Rasilla J; Mitjavila Casanovas M; Cardona Arboniés J; Cubedo R
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):43-9. PubMed ID: 24094372
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer Diagnosis - 18F-sodiumfluorid/18F-FDG-PET/CT shows promising results. ].
    Lichert F
    Rofo; 2013 Oct; 185(10):927. PubMed ID: 24490248
    [No Abstract]   [Full Text] [Related]  

  • 6. [18F-Nsodiumfluorid/18F-FDG-PET/CT shows promising results].
    Lichert F
    Rofo; 2013 Sep; 184(10):927. PubMed ID: 24218685
    [No Abstract]   [Full Text] [Related]  

  • 7. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hybrid PET/CT in cancer imaging].
    Seppänen M; Kajander S; Kemppainen J; Minn H
    Duodecim; 2011; 127(11):1117-27. PubMed ID: 21755803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18-FDG PET/CT staging of ocular sebaceous cell carcinoma.
    Krishna SM; Finger PT; Chin K; Lacob CE
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):759-60. PubMed ID: 17219120
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined 18F-Fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial.
    Cook GJ
    J Nucl Med; 2013 Feb; 54(2):173-5. PubMed ID: 23287576
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the primary staging of rectal cancer.
    Ozis SE; Soydal C; Akyol C; Can N; Kucuk ON; Yagcı C; Erkek AB; Kuzu MA
    World J Surg Oncol; 2014 Feb; 12():26. PubMed ID: 24484935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer": in regard to Guido et al. (Int J Radiat Oncol Biol Phys 2009;73:759-763).
    Schinagl DA; Troost EG; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1629; author reply 1629. PubMed ID: 19515513
    [No Abstract]   [Full Text] [Related]  

  • 13. Positron-emission tomography/computed tomography (PET/CT) in the initial staging of primary rectal cancer.
    Eglinton T; Luck A; Bartholomeusz D; Varghese R; Lawrence M
    Colorectal Dis; 2010 Jul; 12(7):667-73. PubMed ID: 19486092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New trends and novel possibilities in functional medical imaging: imaging methods].
    Balkay L; Emri M; Krizsán KÁ; Opposits G; Varga J
    Magy Onkol; 2015 Mar; 59(1):4-9. PubMed ID: 25763907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
    Gámez-Cenzano C; Pino-Sorroche F
    PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can whole-body MRI replace (18)F-fluorodeoxyglucose PET/CT?
    Kwee TC
    Lancet Oncol; 2014 Mar; 15(3):243-4. PubMed ID: 24559804
    [No Abstract]   [Full Text] [Related]  

  • 19. 18F-FDG PET/CT of transitional cell carcinoma.
    Patil VV; Wang ZJ; Sollitto RA; Chuang KW; Konety BR; Hawkins RA; Coakley FV
    AJR Am J Roentgenol; 2009 Dec; 193(6):W497-504. PubMed ID: 19933624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET in detecting primary breast cancer.
    Kumar R; Lal N; Alavi A
    J Nucl Med; 2007 Oct; 48(10):1751; author reply 1752. PubMed ID: 17909261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.